概述

  • 产品名称Anti-ATP8B1抗体
  • 描述
    兔多克隆抗体to ATP8B1
  • 经测试应用适用于: IHC-Pmore details
  • 种属反应性
    与反应: Human
  • 免疫原

    KIWVLTGDKK ETAENIGFAC ELLTEDTTIC YGEDINSLLH ARMENQRNRG GVYAKFAPPV QESFFPPGGN RALII internal sequence amino acids 727-801 of Human ATP8B1.

  • 阳性对照
    • Human skeletal muscle tissue.

性能

应用

Our Abpromise guarantee covers the use of ab121576 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

应用 Ab评论 说明
IHC-P 1/20 - 1/50. Perform heat mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol. Use buffer at pH 6 for antigen retrieval.

靶标

  • 功能May play a role in the transport of aminophospholipids from the outer to the inner leaflet of various membranes and the maintenance of asymmetric distribution of phospholipids in the canicular membrane. May have a role in transport of bile acids into the canaliculus, uptake of bile acids from intestinal contents into intestinal mucosa or both.
  • 组织特异性Found in most tissues except brain and skeletal muscle. Most abundant in pancreas and small intestine.
  • 疾病相关Defects in ATP8B1 are the cause of progressive familial intrahepatic cholestasis type 1 (PFIC1) [MIM:211600]; also known as Byler disease. PFIC1 is an autosomal recessive disorder, characterized by early infancy cholestasis, that may be initially episodic but progresses to malnutrition, growth retardation and end-stage liver disease before adulthood.
    Defects in ATP8B1 are the cause of benign recurrent intrahepatic cholestasis type 1 (BRIC1) [MIM:243300]; also known as Summerskill syndrome. BRIC is characterized by intermittent episodes of cholestasis without progression to liver failure. There is initial elevation of serum bile acids, followed by cholestatic jaundice which generally spontaneously resolves after periods of weeks to months. The cholestatic attacks vary in severity and duration. Patients are asymptomatic between episodes, both clinically and biochemically.
    Defects in ATP8B1 can be associated with intrahepatic cholestasis of pregnancy (ICP) [MIM:147480]; also known as pregnancy-related cholestasis. ICP is a multifactorial liver disorder of pregnancy. It presents during the second or, more commonly, the third trimestre of pregnancy with intense pruritus which becomes more severe with advancing gestation and cholestasis. Cholestasis results from abnormal biliary transport from the liver into the small intestine. ICP causes fetal distress, spontaneous premature delivery and intrauterine death. ICP patients have spontaneous and progressive disappearance of cholestasis after delivery.
  • 序列相似性Belongs to the cation transport ATPase (P-type) (TC 3.A.3) family. Type IV subfamily.
  • 细胞定位Membrane.
  • Information by UniProt
  • 数据库链接
  • 别名
    • AT8B1_HUMAN antibody
    • ATP8B1 antibody
    • ATPase class I type 8B member 1 antibody
    • ATPase, aminophospholipid transporter, class I, type 8B, member 1 antibody
    • ATPIC antibody
    • BRIC antibody
    • E1-E2 ATPase antibody
    • Familial intrahepatic cholestasis type 1 antibody
    • FIC1 antibody
    • OTTHUMP00000163615 antibody
    • PFIC antibody
    • PFIC1 antibody
    • Phospholipid transporting ATPase IC antibody
    • Probable phospholipid-transporting ATPase IC antibody
    see all

Anti-ATP8B1 antibody 图像

  • ab121576, at a 1/20 dilution, staining ATP8B1 in myocytes of paraffin-embedded Human skeletal muscle tissue by immunohistochemistry.

Anti-ATP8B1 antibody (ab121576)参考文献

ab121576 has not yet been referenced specifically in any publications.

Product Wall

There are currently no Abreviews or Questions for ab121576.
Please use the links above to contact us or submit feedback about this product.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"